These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35768390)

  • 21. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
    Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
    Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Study on the Relationship between Gene Mutation Profile and Prognosis in Pediatric Acute Lymphocyte Leukemia].
    Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
    Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
    Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
    Fang QY; Hao QS; Gong XY; Wang J; Li QH; Yuan T; Tian Z; Liu KQ; Li Y; Liu YT; Gong BF; Wang Y; Wei H; Zhou CL; Lin D; Liu BC; Wei SN; Zhang GJ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):432-435. PubMed ID: 34218589
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mutations of FBXW7 in Adult T-Cell Acute Lymphocytic Leukemia].
    Guo X; Zhang R; Ge Z; Xu JY; Li M; Qiao C; Qiu HR; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):612-8. PubMed ID: 26117003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
    Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
    J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
    Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.
    Mullighan CG
    Haematologica; 2009 Oct; 94(10):1338-40. PubMed ID: 19794079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
    Guan W; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia.
    Liu RB; Guo JG; Liu TZ; Guo CC; Fan XX; Zhang X; Hu WH; Cai XY
    Oncotarget; 2017 Sep; 8(39):66360-66370. PubMed ID: 29029518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
    Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
    Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
    Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
    Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
    Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
    Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Liu J; Guo X; Qiao C; Wu YJ; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1403-8. PubMed ID: 24370020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of FBXW7 gene mutation on the prognosis of immunotherapy in patients with non-small cell lung cancer].
    Liu XY; Cui YN; Li J; Zhang Z; Guo RH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):914-921. PubMed ID: 35385962
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
    Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.